Dr Albrecht Hennig, inventor of the 'Fish Hook Technique' for cataract surgery, will be one of the 'Eye Health Heroes' honoured at the International Agency for the Prevention of Blindness (IAPB) 2012 9th General Assembly.
Dr Albrecht Hennig, inventor of the 'Fish Hook Technique' for cataract surgery, will be one of the 'Eye Health Heroes' honoured at the International Agency for the Prevention of Blindness (IAPB) 2012 9th General Assembly.
The event, to be held in Hyderbad, India from 17–20 September, will play host to a plethora of eyecare professionals including Dr Hennig who runs the Sagarmantha Choudhary Eye Hospital (SCEH), Lahan, Nepal.
Dr Hennig has heavily contributed towards reducing blindness in Nepal with a 79% decrease in the Sagarmatha Zone and a 65% decrease in the Koshi Zone. The SCEH was primarily a 12-bed hospital, but today it has blossomed into a network of two high-volume hospitals and eight eye care centres.
Dr Hennig has completed over 115,000 cataract surgeries on both adults and children. He said, "Seeing this positive change in children and knowing that with their improved vision they will have better chances in life is my biggest reward."
In addition to this, there will be a large scientific program featuring 40 courses, keynote lectures and symposia, as well as a trade exhibition.
To register your place at the IAPB and take advantage of a special discount please visit www.9ga.iapb.org
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.